KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Cash (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Change in Cash for 17 consecutive years, with $134.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 72.68% to $134.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.4 million, a 50.35% decrease, with the full-year FY2025 number at $42.4 million, down 50.35% from a year prior.
  • Change in Cash was $134.0 million for Q4 2025 at Bio-Rad Laboratories, up from $26.5 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $331.5 million in Q1 2022 to a low of -$393.4 million in Q4 2021.
  • A 5-year average of -$6.7 million and a median of $18.5 million in 2021 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: surged 3030.82% in 2022, then plummeted 480.08% in 2025.
  • Bio-Rad Laboratories' Change in Cash stood at -$393.4 million in 2021, then surged by 78.72% to -$83.7 million in 2022, then skyrocketed by 35.65% to -$53.9 million in 2023, then soared by 244.05% to $77.6 million in 2024, then skyrocketed by 72.68% to $134.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Change in Cash are $134.0 million (Q4 2025), $26.5 million (Q3 2025), and -$151.4 million (Q2 2025).